GlassScriptPhysician profile
Andrea D Moody
NPI 1285660365
$220.61
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $15.16.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $55.96 | 2021-2022 | |
| Abbvie INC. | $51.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $33.49 | 2021 | |
| Livanova USA, INC. | $16.90 | 2021 | |
| Kyowa Kirin, INC. | $16.38 | 2021 | |
| Adamas Pharmaceuticals, INC. | $15.79 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.76 | 2021 | |
| Eisai INC. | $14.98 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.